EKSO vs RTX · $42.0M cap vs P/E 36, rev $88.60B
Ekso Bionics Holdings Inc (EKSO) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Ekso Bionics Holdings Inc (EKSO) is a medical instruments & supplies company listed on NASDAQ.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
EKSO does not have a complete income-statement cache yet.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
EKSO currently screens at market cap $42.0M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the EKSO and RTX stock pages for the full models.
Not investment advice.